Vimentin (226-234)

Vimentin

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: ta-048

Synonyms/Alias:Vimentin (226-234)

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
Sequence
SLQEEIAFL
Areas of Interest
Antigen-presenting Cells; Cancer Research

Vimentin (226-234) is a synthetic peptide fragment corresponding to amino acid residues 226 through 234 of the intermediate filament protein vimentin. As a highly conserved cytoskeletal component, vimentin plays a crucial role in maintaining cellular architecture, supporting organelle positioning, and facilitating various dynamic processes such as migration and division in mesenchymal cells. The 226-234 region represents a functionally significant epitope within the vimentin molecule, making this peptide a valuable tool for research into cytoskeletal dynamics, protein-protein interactions, and post-translational modifications. Its defined sequence and biochemical properties enable precise interrogation of vimentin's structural and regulatory roles in cellular systems.

Epitope mapping: The vimentin (226-234) peptide is widely utilized in epitope mapping studies to identify antibody binding sites and characterize immune recognition patterns. By serving as a defined antigenic determinant, this peptide allows researchers to dissect the specificity of monoclonal and polyclonal antibodies raised against vimentin. Such investigations are essential for developing reliable immunodetection assays, generating high-affinity reagents for cell biology, and advancing our understanding of autoimmune responses where vimentin is implicated as an autoantigen.

Protein-protein interaction analysis: As a segment of the vimentin rod domain, the 226-234 peptide can be employed to investigate binding interactions with regulatory proteins, small molecules, or cytoskeletal partners. In vitro binding assays and pull-down experiments using this peptide facilitate the identification of interaction motifs and the elucidation of mechanisms underlying vimentin's role in signaling pathways, cytoskeletal reorganization, and cellular stress responses. These studies contribute to a deeper mechanistic understanding of intermediate filament dynamics in both physiological and pathological contexts.

Phosphorylation and post-translational modification studies: The defined amino acid sequence of vimentin (226-234) provides an ideal substrate for examining phosphorylation events and other post-translational modifications that modulate vimentin function. Researchers can use the peptide in kinase assays to assess site-specific phosphorylation, screen for modifying enzymes, or develop phospho-specific antibodies. Such applications are critical for unraveling how post-translational changes influence vimentin assembly, disassembly, and its integration into broader cellular signaling networks.

Peptide-based assay development: The vimentin (226-234) fragment serves as a standard or competitor in a variety of peptide-based biochemical assays. Its application spans ELISA, competitive binding assays, and mass spectrometry calibration, where it enables the quantification of vimentin or vimentin-derived peptides in complex samples. This functionality supports the development of robust analytical platforms for studying cytoskeletal protein expression, turnover, and fragmentation under different experimental conditions.

Cell signaling research: The 226-234 peptide is also utilized as a molecular probe to interrogate cell signaling pathways in which vimentin is a key mediator. By introducing the peptide into cultured cells or cell-free systems, researchers can assess its impact on filament assembly, intracellular localization, or downstream effector activation. These experiments provide valuable insights into how specific vimentin domains contribute to cellular adaptation, migration, and response to environmental cues, furthering our understanding of the cytoskeleton's regulatory landscape.

Source#
Homo sapiens (human)
Epitope
226-234
Restricting HLA
HLA-A2
References
Alessandra Citro; PLoS One 2015

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
cGMP Peptide ServicePeptide Synthesis ServicesEpitope Mapping ServicesCustom Conjugation ServicePeptide Analysis ServicesPeptide Nucleic Acids SynthesisPeptide Modification ServicesPeptide CDMO
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers